Clinical Trials Logo
  1. Home
  2. TB
  3. NCT04673227

Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)

TB Clinical Trial

Official title:
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI) and the Influence of Previous BCG Vaccination - Pilot Study

Clinical Trial Summary

TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.

Clinical Trial Description

The goal of this project is the verification of current cytometric panel of detection antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells in combination with adjuvants 2 in a in vitro activating test. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04673227
Study type Observational [Patient Registry]
Source Thomayer Hospital
Contact Petra Hadlová, MGR
Phone +724077200
Email Petra.hadlova@natur.cuni.cz
Status Recruiting
Phase
Start date January 2, 2020
Completion date December 26, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04645836 - Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'. N/A
Completed NCT00480454 - Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines Phase 1
Active, not recruiting NCT03208725 - Childhood Acute Illness and Nutrition Network
Completed NCT00480688 - A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers Phase 1
Terminated NCT01055145 - Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients Phase 3
Completed NCT00480714 - A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers N/A
Active, not recruiting NCT04298905 - Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA N/A
Completed NCT00480558 - A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both Phase 1
Withdrawn NCT00424684 - Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation N/A
Completed NCT00654316 - Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine Phase 1
Active, not recruiting NCT05405296 - Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)